ANN ARBOR, MI, Oct., 9–(HSMN NewsFeed)) - Lycera Corp., which is developing novel small-molecule pharmaceuticals to treat autoimmune diseases, today announced the appointments of Paul S. Changelian, Ph.D. and Peter L. Toogood, Ph.D. to the company’s drug …
Biopharmaceuticals, Personnel
Lycera
Posts on ‘October 9th, 2009’
Lycera Appoints Key Executives to Drug Development Team
Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation
Purchase Increases Kimberly-Clark Health Care’s Medical Device Sales by More than Fifty PERCENT and Expands Gross Margins DALLAS and LAKE FOREST, Calif., Oct. 9 (HSMN NewsFeed) — Kimberly-Clark Corporation (NYSE: KMB ) and I-Flow Corporation (Nasdaq: IF…
Devices, Mergers & Acquisitions
Kimberly-Clark, I-Flow

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.